Main > ONCOLOGY (**) > Skin Cancer>CSCC>MET Or Locally>> > TREAT.: > USA. M. PD-1 Binding MAb Inj.

---

USA. M. PD-1 Binding MAb Inj.'s subsections
(*) USA Approval Date: 2020. 06.24>
(*) USA Approval Date: 2021. 07.06>
Company
Generic Name: PembrolizuMAb
Patent>Assignee; Claims; No.; Etc.
PD: Programmed Death
TradeMark
TradeMark Web-Site

USA. M. PD-1 Binding MAb Inj.'s products
This section has no products